Table 6.
MHD patients A−D− |
MHD patients A+D− |
MHD patients A−D+ |
MHD patients A+D+ |
Differences among MHD patients* |
Normal
controls A−D− |
|
---|---|---|---|---|---|---|
MAS | 82±10a | 78±12 | 83±12b | 73±16a,b | =0.0003 | 90±3† |
AAS | 76±14a,c | 64±20c | 74±16b | 63±17a,b | 0.001 | 89±3† |
DPA- 7 day average (vector magnitude) | 415881±142645 | 413229±195863 | 423944±156711 | 322245±124760 | 0.004 | 663304±225019† |
DPA on HD Day | 372469±139164 | 355591±173337 | 380561±201589 | 300361±107871 | 0.004 | -- |
DPA 1 day after HD | 452035±177787 | 465143±232931 | 513005±248927a | 336460±142284a | 0.004 | -- |
DPA 2 days after HD | 435816±175417 | 433774±214628 | 381412±172040 | 364203±186121 | 0.152 | -- |
Abbreviations and symbols are defined in the legends to Tables 2 and 4. Other abbreviations: MAS: Maximum Activity Score; AAS: Adjusted Activity Score.
ANOVA. P-values adjusted for age, gender, presence of diabetes, blood hemoglobin, and dialysis vintage.
Significantly different from values in other columns with the same superscript (p<0.05), as determined by a Tukey’s honestly significant difference (HSD) test for pairwise comparisons (adjusted for age, gender, presence of diabetes, blood hemoglobin, and dialysis vintage).
Normal A−D− controls are significantly different from MHD A−D− patients (adjusted for age, gender, presence of diabetes, blood hemoglobin and dialysis vintage)as determined by Tukey’s HSD test:
p<0.01.